Zimmer Biomet Holdings’ shares collapse at a minimum of more than five years after the publication of its quarterly report

• Zimmer Biomet Holdings (ZBH) falls 10.88% today, reaching minimums not seen since April 2020.
• ZBH obtained a profit per share of $ 1.81, compared to the $ 1,771 planned by analysts.

The values ​​of Zimmer Biomet Holdings (ZBH) established a maximum of the day at $ 99.82, attracting aggressive vendors that dragged the price of the share to minimums not seen since April 3, 2020 in 90.51 $. At the time of writing, ZBH quotes over $ 90.75, losing 10.88% on the first day of the week.

Investors punish Zimmer Biomet Holdings after cutting their annual profit projection

The leading company in developing and marketing medical devices, Zimmer Biomet Holdings (ZBH), records a loss of 10.88% on Monday, reaching minimums not seen since April 3, 2020 in 90.51 $.

ZBH obtained revenues for 1.91 billion dollars, compared to the 1.90 billion dollars projected by the market, as well as an share of $ 1.81 compared to the $ 1,771 estimated by the consensus. Despite marginally exceeding the forecasts, investors showed their rejection when making known that ZBH cut their annual projection of profits per share, placing them in a range at $ 7.90 and $ 8.10 from the previous range of 8.15 $ and $ 8.35.

After these results, Evercore has adjusted the target price of ZBH to 102 $ from $ 116. Similarly, Baird established a new objective price for ZBH at $ 115 from $ 130. In this context, ZBH values ​​lose 11.22 $, quoting when writing about $ 91.13.

Technical levels of ZBH

The shares of Zimmer Biomet Holdings (ZBH) reacted down from a short -term resistance given by May 1 in 103.27 $. The next key resistance is observed at $ 114.44, maximum of April 3. Down, the important support is observed at $ 72.15, pivot point of March 18, 2020.

ZBH daily graphic